John A Jereb
Overview
Explore the profile of John A Jereb including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
443
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Narita M, Hatt G, Gardner Toren K, Vuong K, Pecha M, Jereb J, et al.
Clin Infect Dis
. 2021 May;
73(Suppl 1):S74-S76.
PMID: 33956137
No abstract available.
2.
3.
Mase S, Jereb J, Gonzalez D, Martin F, Daley C, Fred D, et al.
Pediatr Infect Dis J
. 2015 Dec;
35(4):414-21.
PMID: 26658531
Background: In the Federated States of Micronesia and then the Republic of the Marshall Islands (RMI), levofloxacin pharmacokinetics were studied in children receiving directly observed once-daily regimens (10 mg/kg, age...
4.
Kawamura L, Grinsdale J, Ho C, Jereb J
Lancet Infect Dis
. 2012 Jul;
12(8):584.
PMID: 22835892
No abstract available.
5.
Saukkonen J, Powell K, Jereb J
Am J Respir Crit Care Med
. 2012 Mar;
185(6):598-9.
PMID: 22422902
No abstract available.
6.
Jereb J, Privett T, Pearson M
Int J Tuberc Lung Dis
. 2012 Jan;
16(2):279.
PMID: 22236933
No abstract available.
7.
Lewinsohn D, Lobato M, Jereb J
Curr Opin Pediatr
. 2009 Dec;
22(1):71-6.
PMID: 19952926
Purpose Of Review: The testing and treatment of children at risk for Mycobacterium tuberculosis infection represents an important public health priority in the United States. Until recently, diagnosis has relied...
8.
Lobato M, Jereb J, Castro K
Pediatrics
. 2009 Mar;
123(3):902-3.
PMID: 19255018
No abstract available.
9.
Lobato M, Jereb J, Starke J
Pediatrics
. 2008 May;
121(6):e1732-3.
PMID: 18474531
After mandatory school-enrollment tuberculin skin testing, a 4-year-old girl who was at low risk for Mycobacterium tuberculosis infection had severe isoniazid hepatotoxicity that was managed with a liver transplant. Although...
10.
Saukkonen J, Cohn D, Jasmer R, Schenker S, Jereb J, Nolan C, et al.
Am J Respir Crit Care Med
. 2006 Oct;
174(8):935-52.
PMID: 17021358
Drug-induced liver injury (DILI) is a problem of increasing significance, but has been a long-standing concern in the treatment of tuberculosis (TB) infection. The liver has a central role in...